$0.51

-0.05 (-9.43%)

Weekly Expected Move ±10.1%

$0 $0 $1 $1 $1

NYSE · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 24 · $38.7M mcap · 56M float · 2.07% daily turnover · Short 62% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$2.8B -74.2% ▼

5Y CAGR: -56.6%

Gross Profit

$1.2B -45.9% ▼

5Y CAGR: -38.5%

Operating Income

$150M +172.3% ▲

5Y CAGR: -42.5%

Net Income

-$1.1B -203.5% ▼

EPS (Diluted)

$-14.31 -202.5% ▼

EBITDA

$242M +372.0% ▲

5Y CAGR: -55.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2019	FY2020	FY2021	FY2022	FY2025
Revenue	$190.2B	$186.0B	$298.9B	$291.0B	$2.8B
YoY Growth	+5.5%	-2.2%	+60.7%	-2.6%	-74.2%
Cost of Revenue	$177.6B	$173.1B	$262.8B	$258.7B	$1.6B
Gross Profit	$12.6B	$12.8B	$36.1B	$32.3B	$1.2B
Gross Margin	6.6%	6.9%	12.1%	11.1%	43.5%
R&D Expenses	$941M	$1.4B	$2.4B	$4.8B	$0
SG&A Expenses	$2.4B	$2.4B	$3.5B	$4.4B	$1.1B
Operating Expenses	$10.7B	$10.5B	$20.9B	$18.7B	$1.1B
Operating Income	$2.0B	$2.3B	$15.2B	$13.7B	$150M
Operating Margin	1.0%	1.3%	5.1%	4.7%	5.4%
Interest Expense	$5.0B	$4.4B	$4.6B	$3.9B	$129M
Income Before Tax	$2.1B	$2.2B	$14.2B	$13.2B	-$102M
Tax Expense	$628M	$590M	$2.9B	$2.4B	$729K
Net Income	$853M	$764M	$5.8B	$4.2B	-$1.1B
Net Margin	0.4%	0.4%	1.9%	1.4%	-39.8%
EPS (Diluted)	$0.93	$0.74	$8.25	$6.00	$-14.31
EBITDA	$13.2B	$14.0B	$35.9B	$30.0B	$242M
Shares Outstanding	681M	681M	681M	681M	77M

Line Item	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$80.4B	$78.5B	$68.7B	$63.4B	$697M	$709M	$628M	$613M
Cost of Revenue	$72.5B	$67.4B	$61.1B	$57.7B	$375M	$386M	$350M	$350M
Gross Profit	$7.9B	$11.2B	$7.5B	$5.7B	$322M	$323M	$278M	$263M
Gross Margin	9.9%	14.2%	11.0%	9.0%	46.2%	45.6%	44.3%	43.0%
R&D Expenses	$419M	$1.3B	$1.0B	$2.1B	$0	$0	$0	$0
SG&A Expenses	$1.0B	$1.0B	$2.1B	$1.1B	$266M	$271M	$255M	$244M
Operating Expenses	$3.4B	$5.4B	$4.5B	$5.4B	$296M	$271M	$255M	$299M
Operating Income	$4.6B	$5.8B	$3.0B	$296M	$26M	$52M	$23M	-$35M
Operating Margin	5.7%	7.4%	4.4%	0.5%	3.8%	7.3%	3.6%	-5.7%
Interest Expense	$1.0B	$982M	$939M	$871M	$29M	$28M	$32M	$35M
Income Before Tax	$4.5B	$5.7B	$2.9B	$40M	-$4M	-$8M	-$16M	-$88M
Tax Expense	$862M	$692M	$610M	$201M	$2M	$1M	-$10M	$1M
Net Income	$2.0B	$2.4B	$943M	-$1.2B	-$150M	-$56M	-$6M	-$89M
Net Margin	2.5%	3.1%	1.4%	-1.9%	-21.6%	-7.9%	-1.0%	-14.5%
EPS (Diluted)	$3.00	$3.50	$1.39	$-1.87	$-1.94	$-0.73	$-0.08	$-1.16
EBITDA	$8.2B	$10.7B	$7.2B	$4.0B	$89M	$50M	$78M	$13M
Shares Outstanding	681M	676M	681M	681M	77M	77M	77M	77M

ACH NYSE